Recombinant allergen fragments as candidate preparations for allergen immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 I, 1997, Pages 721-727

  Zeiler, Thomas ^a   Taivainen, Antti ^b   Rytkönen, Marja ^a   Rautiainen, Jaakko ^a   Karjalainen, Henry ^a   Mäntyjärvi, Rauno ^a   Tuomisto, Leena ^a   Virtanen, Tuomas ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Allergic asthma; Cow; Fragment; Immunotherapy; Recombinant allergen

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; RECOMBINANT PROTEIN;

ADULT; ANTIGEN BINDING; ARTICLE; ASTHMA; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOTHERAPY; MALE; PRICK TEST; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031398713     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70264-1     Document Type: Article

References (32)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone, I: definition according to profiles of lymphokine activities and secreted protein. J Immunol 1986;136:2348-57.
2. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6:838-46.
3. Ohman JL Jr. Clinical and immunologic responses to immunotherapy. New York: Marcel Dekker, Inc.; 1991. p. 209-32.
4. Mapp CE, Saetta M, Maestrelli P, Distefano A, Chitano P, Boschetto P, et al. Mechanisms and pathology of occupational asthma. Eur Respir J 1994;7:544-54.
5. Liebers V, Sander I, van Kampen V, Raulf-Heimsoth M, Rozynek P, Baur X. Overview on denominated allergens. Clin Exp Allergy 1996;26:494-516.
6. Rogers BL, Bond JF, Craig SJ, Nault AK, Segal DB, Morgenstern JP, et al. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes. Mol Immunol 1994;31:955-66.
7. Ylönen J, Mäntyjärvi R, Taivainen A, Virtanen T. Comparison of the antigenic and allergenic properties of three types of bovine epithelial material. Int Arch Allergy Immunol 1992;99:112-7.
8. Mäntyjarvi R, Parkkinen S, Rytkönen M, Pentikäinen J, Pelkonen J, Rautiainen J, et al. Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family. J Allergy Clin Immunol 1996;97:1297-303.
9. Virtanen T, Zeiler T, Rautiainen J, Taivainen A, Pentikainen J, Rytkönen M, et al. Immune reactivity of cow-asthmatic dairy farmers to the major allergen of cow (BDA20) and to other cow-derived proteins: the use of purified BDA20 increases the performance of diagnostic tests in respiratory cow allergy. Clin Exp Allergy 1996;26: 188-96.
10. Ylönen J, Virtanen T, Rytkönen M, Mäntyjärvi R. Quantification of a major bovine allergen by a two-site immunometric assay based on mAbs. Allergy 1994;49:707-12.
11. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
12. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Vol. 2. New York: Cold Spring Harbor Laboratory Press; 1989.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
14. Ylönen J, Virtanen T, Horsmanheimo L, Parkkinen S, Pelkonen J, Mäntyjärvi R. Affinity purification of the major bovine allergen by a novel monoclonal antibody. J Allergy Clin Immunol 1994;93:851-8.
15. Ylönen J, Mäntyjärvi R, Taivainen A, Virtanen T. IgG and IgE antibody responses to cow dander and urine in farmers with cowinduced asthma. Clin Exp Allergy 1992;22:83-90.
16. Cromwell O, Durham SR, Shaw RJ, MacKay JA, Kay AB. Provocation tests and measurements of mediators from mast cells and basophils in asthma and allergic rhinitis. In: Weir DM, editor. Handbook of experimental immunology. Oxford: Blackwell Scientific Publications; 1986. p. 127.1-127.51.
17. Yamatodani A, Fukuda H, Wada H. Iwaeda T, Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exhange chromatography coupled with post-column derivatization fluorometry. J Chromatogr 1985;344:115-23.
18. Frandsen P, Backman A, Cato Arntzen F, Sjöholm I, Busk M, Larhammar H. Registration of allergen preparations: Nordic guidelines. NLN Publication, No. 23. 2nd ed. Uppsala: Nordic Council on Medicines; 1989. p. 1-34.
19. Virtanen T, Maggi E, Manetti R, Piccinni MP, Sampognaro S, Parronchi P, et al. No relationship between skin-infiltrating Th2-like cells and allergen-specific IgE response in atopic dermatitis. J Allergy Clin Immunol 1995;96:411-20.
20. Dudler T, Chen WQ, Wang S, Schneider T, Annand RR, Dempcy RO, et al. High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim Biophys Acta 1992;1165:201-10.
21. Ferreira FD, Hoffmann-Sommergruber K, Breiteneder H, Pettenburger K, Ebner C, Sommergruber W, et al. Purification and characterization of recombinant Bet v I, the major birch pollen allergen: immunological equivalence to natural Bet v I. J Biol Chem 1993;268:19574-80.
22. Slunt JB, Rogers BL, Chapman MD. IgE antibodies to recombinant forms of Fel d 1: dichotomy between fluid-phase and solid-phase binding studies. J Allergy Clin Immunol 1995;95:1221-8.
23. Batanero E, Villalba M, Rodriguez R. Glycosylation site of the major allergen from olive tree pollen: allergenic implications of the carbohydrate moiety. Mol Immunol 1994;31:31-7.
24. Scheiner O, Kraft D. Basic and practical aspects of recombinant allergens. Allergy 1995;50:384-91.
25. Bond JF, Brauer AW, Segal DB, Nault AK, Rogers BL, Kuo MC. Native and recombinant Fel d I as probes into the relationship of allergen structure to human IgE immunoreactivity. Mol Immunol 1993;30:1529-41.
26. King TP, Kocnoumian L, Lu G. Murine T and B cell responses to natural and recombihant hornet venom allergen Dol m 5.02 and its recombinant fragments. J Immunol 1995;154:577-84.
27. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci U S A 1993;90:7608-12.
28. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T-cell and antibody responses to house dust mite allergen by inhalation of the dominant T-cell epitope in naive and sensitized mice. J Exp Med 1993;178:1783-8.
29. Oshiba A, Hamelmann E, Bradley KL, Loader JE, Renz H, Larsen GL, et al. Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness. Am J Respir Crit Care Med 1996;153:102-9.
30. Ebner C, Schenk S, Szepfalusi Z, Hoffmann K, Ferreira F, Willheim M, et al. Multiple T cell specificities for Bet v I, the major birch pollen allergen, within single individuals: studies using specific T cell clones and overlapping peptides. Eur J Immunol 1993;23:1523-7.
31. Ferreira F, Hirtenlehner K, Jilek A, Godnikcvar J, Breiteneder H, Grimm R, et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
32. Secrist H, Dekruyff RH, Umetsu DT. Interleukin 4 production by CD4(+) T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;181: 1081-9.